Medicare Rx Positioning For 2003: Merck Prepares Investors For Benefit
Executive Summary
Merck is telling investors to expect a "meaningful" Medicare prescription drug benefit in the 108th Congress
You may also be interested in...
GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit
GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13
Senate Medicare Rx Work Begins; Merck Joins In Frist Briefing
Merck is playing a key role in the preliminary Medicare legislative drafting effort in the Senate
GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit
GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13